Sloan Sheldon Insider Trades

Insider Trading History

Track insider trading activity for Sloan Sheldon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $181k 1,834 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$731k 8,334 shares
$87.70
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $825k 8,334 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$741k 8,334 shares
$88.89
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $30.2M 305,000 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$741k 8,334 shares
$88.89
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $31M 313,334 shares
Last Trade
Jun 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$613k 8,333 shares
$73.52
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jun 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$625k 8,333 shares
$75.00
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $825k 8,333 shares
Last Trade
Jun 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$613k 8,333 shares
$73.52
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $7.75M 78,333 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.44M 78,333 shares
$69.42
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $31.8M 321,667 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.44M 78,333 shares
$69.42
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $5.64M 57,027 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.6M 78,333 shares
$71.51
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $8.66M 87,542 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$389k 7,958 shares
$48.90
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$398k 7,958 shares
$50.00
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $787k 7,958 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$389k 7,958 shares
$48.90
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $13.9M 140,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29M 140,000 shares
$30.61
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $9.45M 95,500 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 95,500 shares
$21.66
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Medical Officer
Holding Value $39.6M 400,000 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11M 400,000 shares
$27.46
$98.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up